Neuroangiogenesis: A vascular basis for Alzheimer's disease and cognitive decline during aging

Journal of Alzheimer's Disease

Volumn 32, Issue 3, 2012, Pages 773-788

  Ambrose, Charles T ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; angiogenesis; capillary density; senile dementias; vascular cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN; FIBROBLAST GROWTH FACTOR 2; INSULIN; RECOMBINANT VASCULOTROPIN; RECOMBINANT VASCULOTROPIN 165; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULTHOOD; AGED; AGING; ALZHEIMER DISEASE; ANGIOGENESIS; ARTICLE; BRAIN CAPILLARY; BRAIN PERFUSION; COGNITIVE DEFECT; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; HUMAN; MATURITY; MILD COGNITIVE IMPAIRMENT; MINIPUMP; NEUROANGIOGENESIS; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SENESCENCE; SENILE DEMENTIA;

EID: 84872234801     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120067     Document Type: Article

References (139)

1. AbbottA(2011)Aproblem for our aged. Nature 475, S2-S4.
2. Thies W, Bleiler L (2011) alzheimer's Association Report: 2011 alzheimer's disease facts and figures. Alzheimers Dement 7, 208-244.
3. Ambrose CT (2010) The widening gyrus. American Sci 98, 8-12.
4. Diemer K (1968) Capillarisation and oxygen supply of the brain. In Oxygen Transport in Blood and Tissue, Lubbers DW, ed. Geo. Thieme, Stuttgart, pp. 118-123.
5. Breier G, Albrecht U, Sterrer S, Risau W (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-532.
6. Ment LR, Stewart WB, Fronc R, Seashore C, Mahooti S, Scaramuzzino D, Madri JA (1997) Vascular endothelial growth factor mediates reactive angiogenesis in the postnatal developing brain. Dev Brain Res 100, 52-61. (Pubitemid 27241493)
7. Gorelick PB (2004) Risk factors for vascular dementia and alzheimer disease. Stroke 35, 2620-2622. (Pubitemid 39458352)
8. Craigie EH (1925) Postnatal changes in vascularity in the cerebral cortex of the male albino rat. J Comp Neurol 39, 301-324.
9. Hunziker O, Frey H, Schulz U (1974) Morphometric investigations of capillaries in the brain cortex of the cat. Brain Res 65, 1-11.
10. Bär T (1978) Morphometric evaluation of capillaries in different laminae of rat cerebral cortex by automatic image analysis: Changes during development and aging. Adv Neurology 20, 1-9.
11. Buchweitz-Milton E, Weiss HR (1987) Perfused capillary morphometry in the senescent brain. Neurobiol Aging 8, 271-276. (Pubitemid 17111024)
12. Wang D-B, Blocher NC, Spence ME, Rovainen CM, Woolsey TA (1992) Development and remodeling of cerebral blood vessels and their flow in postnatal mice observed with in vivo videomicroscopy. J Cerebral Blood Flow Metab 12, 935-946.
13. Weiss HR, Buchweitz E, Murtha TL, Auletta ML (1982) Quantitative regional determination of morphometric indices of the total and perfused capillary network in the rat brain. Circ Res 51, 494-503. (Pubitemid 12034489)
14. Rowan RA, Maxwell DS (1981) Patterns of vascular sprouting in the postnatal development of the cerebral cortex of the rat. Am J Anat 160, 247-255. (Pubitemid 11098482)
15. Abernethy WB, Bell MA, Morris M, Moody DM (1993) Microvascular density of the human paraventricuolar nucleus decreases with aging but not hypertension. Exp Neurol 121, 270-274. (Pubitemid 23234747)
16. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, MasonDY(1984)Transferrin receptors on endothelium of brain capillaries. Nature 312, 162-163. (Pubitemid 14000081)
17. Guo L, Burke P, Lo S-H, Gandour-Edwards R, LauD(2001) Quantitative analysis of angiogenesis using confocal laser scanning microscopy. Angiongenesis 4, 187-191. (Pubitemid 34174307)
18. Biron KE, Dickstein DL, Gopaul R, Jefferies WA (2011) Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in alzheimer's disease. Plos One 6, 1-6.
19. Wu Z, Hofman FM, Zlokovic BV (2003) A simple method for isolating and characterizing of mouse brain microvascular endothelial cells. J Neurosci Methods 130, 53-63. (Pubitemid 37315929)
20. Michaelson IC (1948) The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthal Soc UK 68, 137-180.
21. Folkman F (1985) Toward an understanding of angiogenesis: Search and discovery. Perspectives Biol Med 29, 10-36.
22. Folkman J, KlagsbrunM(1987) Angiogenic factors. Science 235, 442-447. (Pubitemid 17009577)
23. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438, 932-936. (Pubitemid 43093958)
24. GospodarowiczD(1974) Localization of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249, 123-127.
25. Dvorak HF, Orenstein NS, Carvalho AC, Churchill WH, Dvorak AM, Galli SJ, Feder J, Bitzer AM, Rypysc J, Giovinco P (1979) Induction of a fibrin-gel investment: An early event in Line 10 hepatocarcinoma growth mediated by tumor-Secreted products. Immunology 122, 166-174. (Pubitemid 9078536)
26. Ferrara N, Leung DW, Phillips HS (1991) Molecular characterization and distribution of vascular endothelial growth factor. J Neuroendocrine Perspect 9, 127-161.
27. Zadeh G, Guha A (2003) Angiogenesis in nervous system disorders. Neurosurgery 53, 1362-1376. (Pubitemid 37484866)
28. Elder JB, Williams G, Lacey E, Gregory H (1978) Cellular localization of human urogastgrone/epidermal growth factor. Nature 271, 466-467. (Pubitemid 8257920)
29. Klagsbrun M, D'Amore PA (1991) Regulators of angiogenesis. Ann Rev Physiol 53, 217-239.
30. Maxwell M, Naber SP, Wolfe HJ, Hedley-Whyte ET, Galanopoulos T, Neville-Golden J, Antoniades HN (1991) Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51, 1345-1351.
31. Bell RD,Winkler EA, Sagare AP, Singh I, LaRue B, Deane R (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427.
32. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-Specific growth factors and blood vessel formation. Nature 407, 242-248.
33. Carmeliet P, JainRK(2011) Molecular mechanism and clinical applications of angiogenesis. Nature 473, 298-307.
34. Thompson PM, Giedd JN,Woods RP, MacDonald D, Evans AC, Toga A (2000) Growth patterns in the developing brain detected by using continuum mechanical tensor maps. Nature 404, 190-193. (Pubitemid 30154487)
35. Ment LR, Stewart WB, Fronc R, Seashore C, Mahooti S, Scaramuzzino D, Madri JA (1997) Vascular endothelial growth factor mediates reactive angiogenesis in postnatal developing brain. Dev Brain Res 100, 52-61. (Pubitemid 27241493)
36. Tannock IF, Hayashi S (1972) The proliferation of capillary endothelial cells. Cancer Res 32, 77-82.
37. Hirst DG, Denekamp J, Hobson B (1980) Proliferation studies on the endothelial and smooth muscle cells of the mouse mesentery after irradiation. Cell Tissue Kinet 13, 91-104. (Pubitemid 10193041)
38. Engerman RL, Pfaffenbach DD, Davis MD (1967) Cell turnover of capillaries. Lab Invest 17, 738-743.
39. Denekamp J (1982) Endothelial cell proliferation as a novel approach to targeting tumour therapy. Brit J Cancer 45, 136-139. (Table, p. 137 (Pubitemid 12207761)
40. Black JE, Polinsky M, Greenough WT (1989) Progressive failure of cerebral angiogenesis supporting neural plasticity in aging rats. Neurobiol Aging 10, 353-358. (Pubitemid 19217976)
41. Bär T, Miodonski A, Budi Santoso AW (1986) Postnatal development of the vascular pattern in the rat telencephalicpia-Arachnoid. Anat Embryo 174, 215-223. (Pubitemid 16069787)
42. Melamed E, Lavy S, Bentin S, Cooper G, Rinot Y (2011) Reduction in regional cerebral blood flow during normal aging in man. Stroke 11, 31-35.
43. Riddle DR, Sonntag WE, Lichtenwalner RJ (2003) Microvascular plasticity in aging. Ageing Res Rev 2, 149-168. (Pubitemid 37443910)
44. Stewart PA, Magliocco M, Hayakawa K, Farrell CL, Del Maestro RF, Girvin J, Kaufmann JC, Vinters HV, Gilbert J (1987) A quantitative analysis of blood-Brain barrier ultrastructure in the aging human. Microvascular Res 33, 270-282. (Pubitemid 17065264)
45. Kuwabara K, Cogan DG (1963) Retinal vascular patterns VI. Mural cell of the retinal capillaries. Arch Ophthamol 69, 114-124.
46. Klein AW, Michel ME (1977) A morphometric study of the neocortex of young adult and old maze-Differentiated rats. Mech Ageing Dev 6, 441-452. (Pubitemid 8211465)
47. de la Torre JC (2000) Critically attained threshold of cerebral hypoperfusion: The CATCH hypothesis of alzheimer's pathogenesis. Neurobiol Aging 21, 331-342. (Pubitemid 30387092)
48. Ferrara N, Houck K, Jakeman L, Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev 13, 18-32.
49. Bell MA, Ball MJ (1981) Morphometric comparison of hippocampal microvasculature in ageing and demented people: Diameters and densities. Acta Neuropathol 53, 299-318. (Pubitemid 11155535)
50. Fisher VW, Siddiqi A, Yusufaly Y (1990) Altered angioarchitecture in selected areas of brains with alzheimer's disease. Acta Neuropathol 79, 672-679. (Pubitemid 20170345)
51. Bu'ee I, Hof PR, Delacourte A (1997) Brain microvascular changes in alzheimer's diseases and other dementias. Ann NY Acad Sci 826, 7-24. (Pubitemid 27478027)
52. Farkas E, Luiten PGM (2001) Cerebral microvascular pathology in aging and alzheimer's disease. Prog Neurobiol 64, 575-611. (Pubitemid 32304447)
53. Jellinger KA (2002) alzheimer disease and cerebrovascular pathology: An update. J Neural Transm 109, 813-836. (Pubitemid 34810776)
54. Perlmutter LS, ChuiHC(1990) Microangiopathy, the vascular basement membrane and alzheimer's disease: A review. Brain Res Bull 24, 677-686. (Pubitemid 20183782)
55. Ravens JR (1978) Vascular changes in the human senile brain. Adv Neurol 20, 487-501.
56. Kalaria RN, Kroon SN (1992) Expression of leukocyte antigen CD34 by brain capillaries in alzheimer's disease and neurologically normal subjects. Acta Neuropathol 84, 606-612.
57. Kalaria RN, Hedera H (1995) Differential degeneration of the cerebral microvasculature in alzheimer's disease. Neuro Report 6, 477-480.
58. Grammas P, Yamada M, Zlokovic B (2002) The cerebromicrovasculature: A key player in the pathogenesis of alzheimer's disease. J Alzheimers Dis 4, 217-223. (Pubitemid 35006053)
59. Kalaria RN, Cohen DL, Premkumar DR, Nag S, LaManna JC, Lust WD (1998) Vascular endothelial growth factor in alzheimer's disease and experimental cerebral ischemia. Mol Brain Res 62, 101-105. (Pubitemid 29023185)
60. Yang S-P, Bae D-G, Kang HJ,Gwag BJ, GhoY-S, Chae C-B (2004) Co-Accumulation of vascular endothelial growth factor with-Amyloid in the brain of patients with alzheimer's disease. Neurobiol Aging 25, 283-290. (Pubitemid 38220962)
61. Pogue AI, Lukiw WJ (2004) Angiogenic signaling in alzheimer's disease. Neuroreport 15, 1507-1510.
62. Stopa EG, Gonzalez A-M, Chorsky R, Corona RJ, Alvarez J, Bird ED, Baird A (1990) Basic fibroblast growth factor in alzheimer's disease. Biochem Biophys Res Commun 171, 690-696. (Pubitemid 20289439)
63. Styren SD, Mufson EJ, Styren GC, Civin WH, Rogers J (1990) Epidermal growth factor receptor expression in demented and aged human brain. Brain Res 347, 347-352. (Pubitemid 20107480)
64. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL,Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H,Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P (2003) VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34, 383-394. (Pubitemid 36935331)
65. Hardy J, Higgins G (1992) alzheimer's disease: The amyloid cascade hypothesis. Science 256, 184-185.
66. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
67. Grammas P (2011) Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of alzheimer's disease. J Neuroinflam 8, 1-12.
68. de la Torre JC, Mussivand T (1993) Can disturbed brain microcirculation cause alzheimer's disease? Neurol Res 15, 146-153. (Pubitemid 23166998)
69. de la Torre JC (1994) Impaired brain microcirculation may trigger alzheimer's disease. Neurosci Biobehav Rev 18, 397-401.
70. de la Torre JC (2002) alzheimer disease as a vascular disorder, nosological evidence. Stroke 33, 1152-1162.
71. de la Torre JC (2010) Vascular risk factor detection and control may prevent alzheimer's disease. Ageing Res Rev 9, 218-225.
72. Brown WR, Moody DM, Thore CR, Challa VR (2000) Apoptosis in leukoaraiosis. Ann NY Acad Sci 21, 79-82. (Pubitemid 30225831)
73. Esiri MM (2000) Which vascular lesions are of importance in vascular dementia? Ann NY Acad Sci 903, 239-243. (Pubitemid 30251563)
74. Hachinski V, Munoz D (2000) Vascular factors in cognitive impairment - where are we now? Ann NY Acad Sci 903, 1-5. (Pubitemid 30251533)
75. Kalback W, Esh C, Casta?no EM, Rahman A, Kokjohn T, Luehrs DC, Sue L, Cisneros R, Gerber F, Richardson C, Bohrmann B, Walker DG, Beach TG, Roher AE (2004) Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic alzheimer's disease. Neurol Res 26, 525-539. (Pubitemid 38879235)
76. Bailey TL, Rivara CB, Rocher AB, Hof PR (2004) The nature and effects of cortical microvascular pathology in aging and alzheimer's disease. Neurol Res 26, 573-578. (Pubitemid 38879242)
77. Roher AE, Esh C, Rahman A, Kokjohn TA, Beach TG (2011) Atherosclerosis of cerebral arteries in alzheimer disease. Stroke 354, 2623-2627.
78. Zlokovic BV (2005) Neurovascular mechanisms of alzheimer's neurodegeneration. Neurosciences 28, 202-208.
79. Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kanagala S, Rubio A, Sagare A, Liu D, Li F, Armstrong D, Gasiewicz T, Zidovetzki R, Song X, Hofman F, Zlokovic BV (2005) Role of the MEOX2 homeobox gene in neurovascular dysfunction in alzheimer disease. Nat Med 11, 959-965. (Pubitemid 41294441)
80. Eisenstein M (2011) Finding risk factors. Nature 475, S20-S22.
81. Deckworth TL, Elliott JL, Knudson CM, Johnson EM Jr, Snider WD, Korsmeyer SJ (1996) BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17, 401-411. (Pubitemid 26322212)
82. Perlman H, Sata M, Le Roux A, Sedlak TW, Branellec D, Walsch K (1998) Bax-mediated cell death by the gaxhomeoprotein requires mitogen activation but is independent of cell cycle activity. EMBO J 17, 3576-3586. (Pubitemid 28327376)
83. Armulik A, Abramsson A, Betsholtz C (2005) Endothelial/ pericyte interactions. Circ Res 97, 512-523.
84. Bell RD,Winkler EA, Sagare AP, Singh I, LaRue B, Deane R (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 8, 409-427.
85. Winkler EA, Bell RD, Zlokovic BV (2011) Central nervous system pericytes in health and disease. Nat Neurosci 14, 1398-1405.
86. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1, 1024-1028.
87. Paris D, Townsend K, Quadros A, Humphrey J, Sun J, Brem S, Wotoczek-Obadia M, DelleDonne A, Patel N, Obregon DF, Crescentini R, Abdullah L, Coppola D, Rojiani AM, Crawford F, Sebti SM,MullanM(2004) Inhibition of angiogenesis by A peptides. Angiogenesis 7, 75-85.
88. Jantaratnotai N, Schwab C, Ryu JK, McGeer PL, McLarnon JG (2010) Converging perturbed microvasculature and microglial clusters characterize alzheimer disease brain. Curr alzheimer Res 7, 625-636.
89. Paris D, Patel N, Delle Donne A, Quadros A, Smeed R, Mullan M (2004) Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366, 80-85. (Pubitemid 38953153)
90. El-Gohary YM, Silverman JF, Olson PR, Liu YL, Cohen JK, Miller R, Saad RS (2007) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma. Am J Clin Pathol 127, 572-579. (Pubitemid 46587470)
91. Vagnucci AH Jr, Li WW (2003) alzheimer's disease and angiogenesis. Lancet 361, 605-608.
92. LaMontague KR (2005) Antiangiogenesis: New frontiers in therapeutic development. Angiogenesis 8, 285-287.
93. Griffin RJ, Molema G, Dings RPM (2006) Angiogenesis treatment, new concepts on the horizon. Angiogenesis 9, 67-72. (Pubitemid 44440551)
94. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF (1994) Angiogenicinduced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183-2189. (Pubitemid 24142797)
95. Takashita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM (1994) Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93, 662-670.
96. Khurana R, Simons M (2003) Insights from angiogenesis trials using fibroblast growth factor for advanced arteriosclerotic disease. TCM 13, 116-122. (Pubitemid 36411807)
97. Puumala M, Anderson RE, Meyer FB (1990) Intraventricular infusion of HBGF-2 promotes cerebral angiogenesis in Wistar rat. Brain Res 534, 283-286.
98. Rosenstein JM, Mani N, Silverman WF, Krum JM (1998) Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci U S A 95, 7086-7091. (Pubitemid 28278111)
99. Hayashi T, Abe K, Toyama Y (1998) Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cerebral Blood Flow Metab 18, 887-895. (Pubitemid 28359907)
100. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, ChoppM(2000) VEGF enhances angiogenesis and promotes blood-Brain barrier leakage in the ischemic brain. J Clin Invest 106, 829-838.
101. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, GreenbergDA(2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111, 1843-1851. (Pubitemid 38057729)
102. Kanya D, Gürsoy-ö zdemir Y, Yemisci M, Tuncer N, Aktan S, Dalkara T (2005) VEGF protects brain against focal ischemia without increasing blood-Brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab 25, 1111-1118. (Pubitemid 41710737)
103. Wang Y, Galvan V, Gorostiza O, Ataie M, Jin K, GreenburgDA (2006)Vascular endothelial growth factor improves recovery of sensorimotor and cognitive deficits after focal cerebral ischemia in the rat. Brain Res 1115, 186-193. (Pubitemid 44436094)
104. Thau-Zuchman O, Shohami E, Alexandrovich AG, Leker RR(2010)Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. J Cereb Blood Flow Metab 30, 1008-1016.
105. Wang P, Xie Z-H, Guo Y-J, Zhao C-P, Jiang H, Song Y, Zhu Z-Y, Lai C, Xu S-L, Bi J-Z (2011) VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of alzheimer's disease. Biochem Biophys Commun 411, 620-626.
106. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-Specific growth factors and blood vessel formation. Nature 407, 242-248.
107. Thurston G (2002) Complementary actions of VEGF and Angiopoietin-1 on blood vessel growth and leakage. J Anat 200, 575-580. (Pubitemid 34823049)
108. Visconti RP, Richardson CD, Sato TN (2002) Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci U S A 99, 8219-8224. (Pubitemid 34651033)
109. Manoonkitiwongsa PS, Schultz RL, McCreery DB, Whitter EF, Lyden PD (2004) Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J Cereb Blood Flow Metab 24, 693-702. (Pubitemid 38725374)
110. Lee JW, Shahzad MM, Lin YG, Armaiz-Pena G, Mangala LS, Han HD, Kim HS, Nam EJ, Jennings NB, Halder J, Nick AM,Stone RL, Lu C, Lutgendorf SK, ColeSW, Lokshin AE, Sood AK (2009) Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 15, 2695-2702.
111. Passam FH, Qi JC, Tanaka K, Matthaei KI, Krilis SA (2010) In vivo modulation of angiogenesis by beta 2 glycoprotein 1. J Autoimmun 35, 232-240.
112. Simcock JW, Penington AJ, Morrison WA, Thompson EW, Mitchell GM (2009) Endothelial precursor cells home to a vascularized tissue engineering chamber by application of the angiogenic chemokine CXCL12. Tissue Eng Part A 15, 655-664.
113. Friden PM, Walus LR, Musso GF, Taylor MA, Malfroy B, Starzyk R (1991) Anti-Transferrin receptor antibody and antibody-Drug conjugates cross the blood-Brain barrier. Proc Natl Acad Sci U S A 88, 4771-4775. (Pubitemid 21914624)
114. Friden PM,Walus LR,Watson P, DoctrowSR,Kozarich JW, Bäckman C, Bergman H, Hoffer B, Bloom F, Granholm AC (1993) Blood-Brain barrier penetration and in vivo activity of an NGF conjugate. Science 259, 373-377. (Pubitemid 23055681)
115. Gill SS, Patel NK, Hotton GR, O'Sullivan K, McCarter R, Bunnage M, Brooks DJ, Svendsen CN, Heywood P (2003) Direct brain infusion of glial cell like-Derived neurotrophic factor in Parkinson Disease. Nat Med 9, 589-595. (Pubitemid 36597106)
116. Kordower JH, Mufson EJ, Granholm A-C, Hoffer B, Friden PM (1993) Delivery of trophic factors to the primate brain. Exp Neurology 124, 21-30. (Pubitemid 24041746)
117. Ai Y, Markesbery W, Zhang Z, Grondin R, Elseberry D, Gerhardt GA, Gash DM (2003) Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects. J Comp Neurology 461, 250-261. (Pubitemid 36583466)
118. Kumar A, Jena PK, Behera S, Subhra Mohapatra RL, Mohapatra S (2010) Multifunctional magnetic nanoparticles for targeted delivery. Nanomedicine 6, 64-69.
119. Vatta LL, Sanderson RD, Koch KR (2006) Magnetic nanoparticles: Properties and potential applications. Pure Appl Chem 78, 1793-1801.
120. Chorny M, Fishbein I, Yellen BB, Alferiev IS, Bakay M, Ganta S, Adamo R, Amiji M, Friedman G, Levy RJ (2010) Targeting stents with local delivery of paclitaxel-Loaded magnetic nanoparticles using uniform fields. Proc Natl Acad Sci U S A 107, 8346-8351.
121. Langer R, Folkman J (1976) Polymer for the sustained release of proteins and other macromolecules. Nature 263, 797-800.
122. Creque HM, Langer R, Folkman J (1980) One month of sustained release of insulin from a polymer implant. Diabetes 29, 37-40. (Pubitemid 10157187)
123. Kurachi K, Davie EW, Strydom DJ, Riordan JF, Valee BL (1985) Sequence of the cDNA and gene for angiongenin, a human angiongenesis factor. Biochemistry 124, 5494-5499. (Pubitemid 16228830)
124. Murray JB, Brown L, Langer R, Klagsburn M (1983) A micro sustained release system for epidermal growth factor. In Vitro 19, 743-748. (Pubitemid 15218464)
125. Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, BremH(2008) Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience. Ann Surg Oncology 15, 2887-2893.
126. McGirt MJ, Brem H (2010) Carmustine wafer (Gliadel)plus comcomitant temozolomide therapy after resection of malignant astrocytoma: Growing evidence for safety and efficacy. Ann Surg Oncol 17, 1729-1731.
127. Slager J, Tyler B, Shikanov A, Domb AJ, Shogen K, Sidransky D, Brem H (2009) Local controlled delivery of antineoplastic RNAse to the brain. Pharm Res 26, 1838-1846.
128. Tyler B, Fowers KD, Li KW, Recinos VR, Caplan JM, Hdeib A, Grossman R, Basaldella L, Bekelis K, Pradilla G, Legnani F, Brem H (2010) A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats. J Neurosurg 113, 210-217.
129. Scott AW, Tyler BM, Masi BC, Upadhyay UM, Patta YR, Grossman R, Basaldella L, Langer RS, Brem H, Cima MJ (2011) Intracranial microcapsule drug delivery device for the treatment of an experimental gliosarcoma model. Biomaterials 32, 2532-2539.
130. Tyler B,Wadsworth S, Recinos V, Mehta V, Vellimana A, Li K, Rosenblatt J, Do H, Gallia GL, Siu IM,Wicks RT, Rudek MA, Zhao M, Brem H (2011) Local delivery of rapamycin: A toxicity and efficacy study in an experimental malignant glioma model in rats. Neuro-Oncology 13, 700-709.
131. Stewart TD (1957) Stone age skull surgery: A general review, with emphasis on the new world. Ann Rep Smithsonian Inst 469, 469-491.
132. Shipley MT (1995) Transport of molecules from nose to brain:Transneural anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium. Brain Res Bull 15, 129-142.
133. Illum I (2000) Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11, 1-18.
134. Chen X-Q, Fawcett JR, Rahman Y-E, Ala TA, Frey WH II (1989) Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimers Dis 1, 35-44.
135. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B (2012) Intranasal insulin therapy for alzheimer disease and amnestic mild cognitive impairment. Arch Neurol 69, 29-38.
136. Magliore MM, Vyas TK, Campbell RB, Amiji MM, Waszczak BL (2010) Brain delivery of proteins by the intranasal route of administration: A comparison of cationic liposomes versus aqueous solution formulations. J Pharm Sci 99, 1745-1761.
137. Dhuria SV, Hanson LR, Frey WH II (2010) Intranasal delivery to the central nervous system: Mechanisms and experimental considerations. J Pharm Sci 99, 1654-1673.
138. Malerba F, Paoletti F, Capsoni S, Cattaneo A (2011) Intranasal delivery of therapeutic proteins for neurological diseases. Expert Opin Drug Deliv 8, 1277-1296.
139. Thorne RG, Pronk GJ, Padmanabhan V, FreyWH II (2004) Delivery of insulin-Like growth factor-1 to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127, 481-496. (Pubitemid 38950662)